HLA antigens associated with susceptibility/resistance to HIV-1 infection

Human Immunology

Volumn 59, Issue 12, 1998, Pages 802-815

  Rohowsky Kochan, Christine ^a   Skurnick, Joan ^a   Molinaro, Donna ^a   Louria, Donald ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ALLELE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; HLA TYPING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL;

ALLELES; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HETEROSEXUALITY; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV-1; HLA ANTIGENS; HUMANS; MALE; POLYMORPHISM, GENETIC;

EID: 0032402287     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(98)00086-X     Document Type: Article

References (40)

1. Friedman-Kien A.E. Disseminated Kaposi's sarcoma syndrome in young homosexual men. J Am Acad Derm. 5:1981;468.
2. Pollack M.S., Safai B., Myskowski P.L., Gold J.W., Pandey J., Dupont B. Frequencies of HLA and Gm immunogenetic markers in Kaposi's sarcoma. Tissue Antigens. 21:1983;1.
3. Pollack M.S., Safai B., Dupont B. HLA-DR5 and DR2 are susceptibility factors for acquired immunodeficiency syndrome with Kaposi's sarcoma in different ethnic subpopulations. Disease Markers. 1:1983;135.
4. Prince H.E., Schroff R.W., Ayoub G., Han S., Gottlieb M.S., Fahey J.L. HLA studies in acquired immunodeficiency syndrome patients with Kaposi's sarcoma. J Clin Immunol. 3:1984;242.
5. Contu L., Cerimele D., Pintus A., Cottoni F., LaNasa G. HLA and Kaposi's sarcoma in Sardinia. Tissue Antigens. 23:1984;240.
6. Pollack M.S., Gold J., Metroka C.E., Safai B., Dupont B. HLA-A, B, C and DR antigen frequencies in acquired immunodeficiency syndrome (AIDS) patients with opportunistic infections. Hum Immunol. 11:1984;99.
7. Klein M.R., Keet I.P.M., D'Amaro J., Bende R.J., Hekman A., Mesman B., Koot M., de Waal L.P., Coutinho R.A., Miedema F. Associations between HLA frequencies and pathogenic features of human immunodeficiency virus type 1 infection in seroconverters from the Amsterdam cohort of homosexual men. J Infect Dis. 169:1994;1244.
8. Mann D.L., Murray C., Yarchoan R., Blattner W.A., Goedert J.J. HLA antigen frequencies in HIV-1 seropositive disease-free individuals and patients with AIDS. J AIDS. 1:1988;13.
9. Enlow R.W., Roldan A.N., LoGalbo P., Mildvan D., Mathur U., Winchester R.J. Increased frequency of HLA-DR5 in lymphadenopathy stage of AIDS. Lancet. i:1983;51.
10. DePaoli P., Reitano M., Martelli P., Battistin S., Villalta D., Carbone A., Tirelli U., Santini G. Persistent generalized lymphadenopathy in northern Italy increased frequency of HLA-DR5 . Tissue Antigens. 27:1986;116.
11. Raffoux C., David V., Couderc L.D., Rabian C., Clauvel J.P., Seligmann M., Colombani J. HLA-A, B and DR antigen frequencies in patients with AIDS-related persistent generalized lymphadenopathy (PGL) and thrombocytopenia. Tissue Antigens. 29:1987;60.
12. Smeraldi R.S., Fabio G., Lazzarin A., Eisera N.B., Moroni M., Zanussi C. HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human immunodeficiency-virus infection. Lancet. i:1986;1187.
13. Smeraldi R.S., Fabio G., Lazzarin A., Eisera N.B., Foppa C.U., Moroni M., Zanussi C. HLA-associated susceptibility to AIDS HLA B35 is a major risk factor for Italian HIV-infected intravenous drug addicts . Hum Immunol. 22:1988;73.
14. Jeannet M., Sztajzel R., Carpentier N., Hirschel B., Tiercy J.M. HLA antigens are risk factors for development of AIDS. J AIDS. 2:1989;28.
15. Steel C.M., Ludlam C.A., Beatson D., Peutherer J.F., Cuthbert R.J.G., Simmonds P., Morrison H., Jones M. HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease. Lancet. i:1988;1185.
16. Fabio G., Smeraldi R.S., Gringeri A., Marchini M., Bonara P., Mannucci P.M. Susceptibility to HIV infection and AIDS in Italian haemophiliacs is HLA associated. Br J Haematol. 75:1990;531.
17. Fabio G., Scorza R., Lazzarin A., Marchini M., Zarantonello M., D'Arminio A., Marchisio P., Plebani A., Luzzati R., Costigliola P. HLA-associated susceptibility to HIV-1 infection. Clin Exp Immunol. 87:1992;20.
18. Cruse J.M., Brackin M.N., Lewis R.E., Meeks W., Nolan R., Brackin B. HLA disease association and protection of HIV infection among African Americans and Caucasians. Pathobiology. 59:1991;324.
19. Cornu F., Raffoux C., Maisonneuve P., Bardin J.M., Sultan Y., Colombani J. HLA typing in heavily transfused haemophiliacs with or without antibodies against human immunodeficiency virus (HIV). Tissue Antigens. 29:1987;123.
20. Kaplan C., Muller J.Y., Doinel C., Lefrere J.J., Paquez F., Rouger P., Salmon D., Salmon C. HLA-associated susceptibility to acquired immune deficiency syndrome in HIV-1-seropositive subjects. Human Heredity. 40:1990;290.
21. Svejgaard A., Dickmeiss E., Jakobsen B.K., Madsen H.O., Ryder L.P., Svejgaard P., Andersen M. HLA in HIV infection results of a European collaborative study . Tsuji K., Aizawa M., Sasazuki T. HLA 1991 Proceedings of the 11th International Histocompatibility Workshop and Conference . Vol. 2:1992;Oxford University Press, Oxford, UK.
22. Skurnick J.H., Kennedy C.A., Perez G., Abrams J., Fermund S.H., Denny T., Wright T., Quinones M., Louria D.D. Behavioral and psychosocial risk factors for HIV-1 transmission in heterosexual couples a report from the Heterosexual HIV Transmission Study (HATS) . Clin Infect Dis. 26:1998;855.
23. Bruning H.U., Kardon M.J., Arentzen R., Naipal A., Van Der Poel J.J. Carboxyfluoresein fluorochromasia assay for cell-mediated lympholysis and antibody-dependent cellular cytotoxicity - a non-radioactive technique. Trans Proc. 11:1979;1961.
24. Bodmer J.G., Marsh S.G.E., Albert E.D., Bodmer W.F., Dupont B., Erlich H.A., Mach B., Mayr W.R., Parham P., Sasazuki T., Schreuder G.M.Th., Strominger J.L., Svejgaard A., Terasaki P.I. Nomenclature for factors of the HLA system, 1991. Hum Immunol. 34:1992;4.
25. Imanishi T., Akaza T., Kimura A., Tokunaga K., Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. Tsuji K., Aizawa M., Sasazuki T. HLA 1991 Proceedings of the 11th International Histocompatibility Workshop and Conference . Vol. 1:1992;Oxford University Press.
26. Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology. 1:1990;43.
27. Arnett K.L., Parham P. HLA class I nucleotide sequences, 1995. Tissue Antigens. 46:1995;217.
28. Krausa P., Brywka M. III, Savage D., Hui K.M., Bunce M., Ngai J.L., Teo D.L., Ong Y.W., Barouch D., Allsopp C.E.M., Hill A.V.S., McMichael A.J., Bodmer J.G., Browning M.J. Genetic polymorphism within HLA-A *02 significant allelic variation revealed in different populations . Tissue Antigens. 45:1995;223.
29. Jersild G., Fog T., Hansen G.S., Thomsen M., Svejgaard A., Dupont B. Histocompatibility determinants in multiple sclerosis, with special reference to clinical course. Lancet. ii:1973;1221.
30. Tiwari J.L., Hodge S.E., Terasaki P.I., Spense M.A. HLA and the inheritance of multiple sclerosis linkage analysis of 72 pedigrees . Am J Hum Gen. 32:1980;103.
31. Smith M.W., Dean M., Carrington M., Winkler C., Huttley G.A., Lomb D.A., Goedert J.J., O'Brien T.R., Jacobson L.P., Kaslow R., Buchbinder S., Vittinghoff E., Vlahov D., Hoots K., Hilgartner M.W., O'Brien S.J. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science. 277:1997;959.
32. Hoffenbach A., Langlade-Demoyen P.X., Dadaglio G. Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J Immunol. 142:1989;452.
33. Cheynier R., Langlade-Demoyen P., Marescot M.R., Blanche S., Blondin G., Wain-Hobson S., Griscelli C., Vilmer E., Plata F. Cytotoxic T lymphocyte response in the peripheral blood of children born to HIV-1 infected mothers. Eur J Immunol. 22:1992;2211.
34. Clerici M., Giorgi J.V., Chou C.C., Gudeman V.K., Zack J.A., Gupta P., Ho H.-N., Nishanian P.G., Berzofsky J.A., Shearer G.M. Cell-mediated immune response to human immunodeficiency virus (HIV) type-1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis. 165:1992;1012.
35. Rowland-Jones S.L., Nixon D.F., Aldhous M.C., Gotch F.M., Ariyoshi K., Hallam N., Kroll J.S., Froebel K., McMichael A.J. HIV-specific T-cell activity in an HIV-exposed but uninfected infant. Lancet. 341:1993;860.
36. Langlade-Demoyen P., Ngo-Giang-Huong N., Ferchal F., Oksenhendler E. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. J Clint Invest. 93:1994;1293.
37. Delassus S., Cheynier R., Wain-Hobson S. Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro. J Virol. 65:1991;225.
38. Hill A.V.S., Elvin J.G., Willis A.C., Aidoo M., Allsopp C.E.M., Gotch F.M., Ming Gao X., Takiguchi M., Greenwood B.M., Townsend A.R.M., McMichael A.J., Whittle H.C. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature. 360:1992;434.
39. Phillips R.E., Rowland-Jones S.L., Nixon D.F., Gotch F.M., Edwards J.P., Ogunlesi A.O., Elvin J.G., Rothbard J.A., Bangham C.R., Rizza C.R., McMichael A.J. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature. 354:1991;453.
40. Meyerhans A., Dadaglio G., Vartanian J.P., Langlade-Demoyen P., Frank R., Asjo B., Plata F., Wain-Hobson S. In vivo persistance of a HIV-1 encoded HLA-B27-restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivity. Eur J Immunol. 21:1991;2637.